• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

幽门螺杆菌对胃粘蛋白的糖硫酸酯酶活性。

Glycosulfatase activity of Helicobacter pylori toward gastric mucin.

作者信息

Slomiany B L, Murty V L, Piotrowski J, Liau Y H, Sundaram P, Slomiany A

机构信息

Research Center, New Jersey Dental School, University of Medicine and Dentistry of New Jersey, Newark 07103-2400.

出版信息

Biochem Biophys Res Commun. 1992 Mar 16;183(2):506-13. doi: 10.1016/0006-291x(92)90511-i.

DOI:10.1016/0006-291x(92)90511-i
PMID:1372502
Abstract

A glycosulfatase activity toward sulfated gastric mucus glycoprotein was identified in the extracellular material elaborated by H. pylori, a bacteria implicated in the etiology of gastric disease. Upon acetone precipitation, an active enzyme fraction at 64% acetone was obtained which on SDS-PAGE gave a major 30kDa protein band. The H. pylori glycosulfatase exhibited maximum activity (314.8 pmol/mg protein/h) at pH 5.7 in the presence of Triton X-100 and CaCl2, and was capable of removal of the sulfate ester groups situated at C-6 of N-acetylglucosamine, galactose and glucose. However, the enzyme was ineffective toward galactosylceramide and lactosylceramide sulfates which contain the sulfate ester group on C-3 of galactose. The results suggest that H. pylori is capable of overcoming the interference by sulfated mucus glycoprotein with its colonization of gastric mucosa.

摘要

在由幽门螺杆菌(一种与胃部疾病病因有关的细菌)产生的细胞外物质中,发现了一种针对硫酸化胃黏液糖蛋白的糖硫酸酯酶活性。经丙酮沉淀后,获得了在64%丙酮浓度下的活性酶组分,该组分在SDS - PAGE上呈现出一条主要的30kDa蛋白条带。幽门螺杆菌糖硫酸酯酶在pH 5.7、存在Triton X - 100和CaCl2的条件下表现出最大活性(314.8 pmol/mg蛋白/小时),并且能够去除位于N - 乙酰葡糖胺、半乳糖和葡萄糖C - 6位的硫酸酯基团。然而,该酶对在半乳糖C - 3位含有硫酸酯基团的半乳糖神经酰胺和乳糖神经酰胺硫酸盐没有作用。结果表明,幽门螺杆菌能够克服硫酸化黏液糖蛋白对其在胃黏膜定植的干扰。

相似文献

1
Glycosulfatase activity of Helicobacter pylori toward gastric mucin.幽门螺杆菌对胃粘蛋白的糖硫酸酯酶活性。
Biochem Biophys Res Commun. 1992 Mar 16;183(2):506-13. doi: 10.1016/0006-291x(92)90511-i.
2
Glycosulfatase activity of H. pylori toward human gastric mucin: effect of sucralfate.幽门螺杆菌对人胃黏蛋白的糖硫酸酯酶活性:硫糖铝的作用
Am J Gastroenterol. 1992 Sep;87(9):1132-7.
3
Inhibition of Helicobacter pylori glycosulfatase activity toward gastric sulfomucin by nitecapone.硝替卡朋对幽门螺杆菌针对胃硫黏蛋白的糖硫酸酯酶活性的抑制作用。
Biochem Int. 1992 May;26(6):1091-9.
4
Glycosulfatase activity of Helicobacter pylori towards gastric sulfomucin: effect of nitecapone.幽门螺杆菌对胃硫黏蛋白的糖硫酸酯酶活性:恩他卡朋的作用
J Physiol Pharmacol. 1993 Mar;44(1):7-16.
5
Inhibition of Helicobacter pylori glycosulfatase activity towards human gastric sulfomucin by a gastroprotective agent, sulglycotide.胃保护剂舒糖肽对幽门螺杆菌糖硫酸酯酶作用于人胃硫黏蛋白活性的抑制作用
Gen Pharmacol. 1993 Nov;24(6):1463-6. doi: 10.1016/0306-3623(93)90436-2.
6
Glycosulfatase activity of Porphyromonas gingivalis a bacterium associated with periodontal disease.牙龈卟啉单胞菌的糖硫酸酯酶活性,牙龈卟啉单胞菌是一种与牙周病相关的细菌。
Biochem Mol Biol Int. 1993 Apr;29(5):973-80.
7
Gastroprotective agents in mucosal defense against Helicobacter pylori.用于黏膜防御幽门螺杆菌的胃保护剂。
Gen Pharmacol. 1994 Sep;25(5):833-41. doi: 10.1016/0306-3623(94)90084-1.
8
Mechanism of Helicobacter pylori pathogenesis: focus on mucus.幽门螺杆菌致病机制:聚焦于黏液
J Clin Gastroenterol. 1992;14 Suppl 1:S114-21.
9
Helicobacter pylori moves through mucus by reducing mucin viscoelasticity.幽门螺杆菌通过降低粘蛋白的粘弹性在黏液中移动。
Proc Natl Acad Sci U S A. 2009 Aug 25;106(34):14321-6. doi: 10.1073/pnas.0903438106. Epub 2009 Aug 11.
10
Effects of pH on Helicobacter pylori binding to human gastric mucins: identification of binding to non-MUC5AC mucins.pH对幽门螺杆菌与人胃黏蛋白结合的影响:与非MUC5AC黏蛋白结合的鉴定
Biochem J. 2004 Dec 1;384(Pt 2):263-70. doi: 10.1042/BJ20040402.

引用本文的文献

1
Oral probiotic activities and biosafety of Lactobacillus gasseri HHuMIN D.干酪乳杆菌 HHuMIN D 的口腔益生菌活性及生物安全性
Microb Cell Fact. 2021 Mar 23;20(1):75. doi: 10.1186/s12934-021-01563-w.
2
Isolation, Characterization and Biosafety Evaluation of Lactobacillus Fermentum OK with Potential Oral Probiotic Properties.具有潜在口服益生菌特性的发酵乳杆菌 OK 的分离、鉴定及生物安全性评价。
Probiotics Antimicrob Proteins. 2021 Oct;13(5):1363-1386. doi: 10.1007/s12602-021-09761-z. Epub 2021 Mar 13.
3
Aerobic Metabolism in Vibrio cholerae Is Required for Population Expansion during Infection.
霍乱弧菌有氧代谢是感染期间种群扩张所必需的。
mBio. 2020 Sep 1;11(5):e01989-20. doi: 10.1128/mBio.01989-20.
4
" Interactions With The Host: Crossing The Intestinal Epithelial Barrier".与宿主的相互作用:跨越肠道上皮屏障
Tissue Barriers. 2019;7(2):1612661. doi: 10.1080/21688370.2019.1612661. Epub 2019 Jun 12.
5
Mucin glycan foraging in the human gut microbiome.人类肠道微生物群中的粘蛋白聚糖觅食
Front Genet. 2015 Mar 19;6:81. doi: 10.3389/fgene.2015.00081. eCollection 2015.
6
Mimicking microbial strategies for the design of mucus-permeating nanoparticles for oral immunization.模仿微生物策略设计用于口服免疫的可渗透黏液纳米颗粒。
Eur J Pharm Biopharm. 2015 Oct;96:454-63. doi: 10.1016/j.ejpb.2015.01.010. Epub 2015 Jan 20.
7
Mucin-bacterial interactions in the human oral cavity and digestive tract.人类口腔和消化道中的黏液-细菌相互作用。
Gut Microbes. 2010 Jul;1(4):254-268. doi: 10.4161/gmic.1.4.12778. Epub 2010 Jun 23.
8
Colonization of mucin by human intestinal bacteria and establishment of biofilm communities in a two-stage continuous culture system.人肠道细菌对黏蛋白的定殖以及在两阶段连续培养系统中生物膜群落的建立。
Appl Environ Microbiol. 2005 Nov;71(11):7483-92. doi: 10.1128/AEM.71.11.7483-7492.2005.
9
Helicobacter pylori infection does not reduce the viscosity of human gastric mucus gel.幽门螺杆菌感染不会降低人胃黏液凝胶的黏度。
Gut. 1995 Mar;36(3):327-9. doi: 10.1136/gut.36.3.327.